AU2001265949A1 - Transdermal therapeutical system with a reduced tendency of the active substanceto crystallize - Google Patents

Transdermal therapeutical system with a reduced tendency of the active substanceto crystallize

Info

Publication number
AU2001265949A1
AU2001265949A1 AU2001265949A AU6594901A AU2001265949A1 AU 2001265949 A1 AU2001265949 A1 AU 2001265949A1 AU 2001265949 A AU2001265949 A AU 2001265949A AU 6594901 A AU6594901 A AU 6594901A AU 2001265949 A1 AU2001265949 A1 AU 2001265949A1
Authority
AU
Australia
Prior art keywords
substanceto
crystallize
active
reduced tendency
therapeutical system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001265949A
Other languages
English (en)
Inventor
Robert-Peter Klein
Reinhold Meconi
Frank Seibertz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of AU2001265949A1 publication Critical patent/AU2001265949A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001265949A 2000-05-25 2001-05-12 Transdermal therapeutical system with a reduced tendency of the active substanceto crystallize Abandoned AU2001265949A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10025971 2000-05-25
DE10025971A DE10025971B4 (de) 2000-05-25 2000-05-25 Transdermales therapeutisches System in Plasterform mit verminderter Tendenz zur Wirkstoffkristallisation und seine Verwendung
PCT/EP2001/005438 WO2001089487A1 (de) 2000-05-25 2001-05-12 Transdermales therapeutisches system mit verminderter tendenz zur wirkstoffkristallisation

Publications (1)

Publication Number Publication Date
AU2001265949A1 true AU2001265949A1 (en) 2001-12-03

Family

ID=7643564

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001265949A Abandoned AU2001265949A1 (en) 2000-05-25 2001-05-12 Transdermal therapeutical system with a reduced tendency of the active substanceto crystallize

Country Status (9)

Country Link
US (1) US20030175330A1 (ko)
EP (1) EP1283705A1 (ko)
JP (1) JP2003534271A (ko)
KR (1) KR20030001556A (ko)
AR (1) AR028611A1 (ko)
AU (1) AU2001265949A1 (ko)
CA (1) CA2410336A1 (ko)
DE (1) DE10025971B4 (ko)
WO (1) WO2001089487A1 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10211832A1 (de) * 2002-03-16 2003-10-02 Lohmann Therapie Syst Lts Hormonhaltiges transdermales therapeutisches System mit einem Wirkstoffreservoir auf der Basis von Vinylacetat-Vinylpyrrolidon-Copolymer mit verbesserter Kohäsion
DE10304988A1 (de) * 2003-02-07 2004-09-09 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System mit verbessertem Hautklebeverhalten
PL219512B1 (pl) * 2003-04-14 2015-05-29 Lohmann Therapie Syst Lts Plaster miejscowy, zastosowanie plastra miejscowego i sposób wytwarzania plastra miejscowego

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4624665A (en) * 1984-10-01 1986-11-25 Biotek, Inc. Method of transdermal drug delivery
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
US5676968A (en) * 1991-10-31 1997-10-14 Schering Aktiengesellschaft Transdermal therapeutic systems with crystallization inhibitors
FR2699406B1 (fr) * 1992-12-21 1995-03-10 Commissariat Energie Atomique Films à base de copolymères, leurs applications dans des systèmes transdermiques et leurs procédés de préparation.
DE69401945T3 (de) * 1993-06-25 2004-09-02 Alza Corp., Palo Alto Einarbeitung eines poly-n-vinylamids in ein transdermales system
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
DE19500662C2 (de) * 1995-01-12 2001-04-26 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster und seine Verwendung
FR2732223B1 (fr) * 1995-03-30 1997-06-13 Sanofi Sa Composition pharmaceutique pour administration transdermique
US5928666A (en) * 1996-11-12 1999-07-27 Cygnus Inc. Crystalline form of estradiol and pharmaceutical formulations comprising same
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
DE19828274C2 (de) * 1998-06-25 2002-11-28 Rottapharm Bv Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
DE19830651A1 (de) * 1998-07-09 2000-01-13 Lohmann Therapie Syst Lts Steroidhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung
AU3104301A (en) * 2000-01-20 2001-07-31 Noven Pharmaceuticals, Inc. Compositions and methods to effect the release profile in the transdermal administration of active agents

Also Published As

Publication number Publication date
EP1283705A1 (de) 2003-02-19
JP2003534271A (ja) 2003-11-18
CA2410336A1 (en) 2001-11-29
DE10025971B4 (de) 2004-09-02
US20030175330A1 (en) 2003-09-18
DE10025971A1 (de) 2001-12-06
AR028611A1 (es) 2003-05-14
KR20030001556A (ko) 2003-01-06
WO2001089487A1 (de) 2001-11-29

Similar Documents

Publication Publication Date Title
AU2002234525A1 (en) Transdermal therapeutic system comprising the active ingredient oxybutynin
EG24411A (en) Pharmaceutically active compounds
AU7224396A (en) Pharmaceutically active quinazoline compounds
GB9924020D0 (en) Pharmaceutically active compounds
AU5259100A (en) Medicament
AU4836200A (en) Steerable catheter
AUPQ346399A0 (en) Stable idle procedure
AU2002210463A1 (en) Transdermal therapeutic system
AU6294199A (en) Fastener
AUPQ253199A0 (en) Non-prostanoid prostaglandin I2-agonist
AU2186501A (en) Dynamic deviation
AU752953C (en) Adding pharmaceutically active compounds to substrates
AU2080199A (en) New pharmaceutically active compounds
AU7961300A (en) Kainic acid neurocytotoxicity inhibitors
AU6036100A (en) New pharmaceutically active compounds
AU2543600A (en) Fungicidal active substance combinations
AU2002217073A1 (en) Spray catheter
AU2001265949A1 (en) Transdermal therapeutical system with a reduced tendency of the active substanceto crystallize
AU5405600A (en) Pesticidally active tetrazine derivatives
AU2001239311A1 (en) Novel imidazole derivatives with anti-inflammatory activity
AU3714800A (en) Hiv therapy
AU2682800A (en) Self watering growing unit
AU2727400A (en) Moxonidine salts
AU7990000A (en) Neuraminidase inhibitors
AU7272800A (en) Pleuromutilin beta-ketoesters